This bill amends Section 2-309 of Title 63 of the Oklahoma Statutes, which pertains to the prescription of controlled dangerous substances. It establishes that, with certain exceptions, no controlled dangerous substance classified as Schedule II can be dispensed without an electronic prescription from a practitioner. The bill outlines specific exemptions to this requirement, including practitioners facing temporary technological failures, those dispensing directly to patients, and practitioners operating in medically underserved areas. Additionally, it mandates that licensing boards communicate with the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control regarding practitioners who have been subject to disciplinary actions related to controlled substances.

The bill also updates statutory language and clarifies the definitions of prescriptions and registered practitioners. It specifies that prescriptions for Schedule III, IV, and V substances must also be electronic, with limitations on refills and the time frame for filling prescriptions. The effective date for this legislation is set for November 1, 2025. Overall, the bill aims to enhance the regulation of prescription practices for controlled substances while providing necessary exemptions to ensure patient care is not compromised.